Quick Takeaways
- Colin McCracken has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $201,082.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Colin McCracken
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Colin McCracken is at least $201,082 dollars as of 24 Feb 2022. Colin McCracken is the Chief Commercial Officer of FLUIDIGM CORP and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $201.1K.
- Signature
- /s/ Colin McCracken by Nicholas Khadder, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Colin McCracken and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: FLUIDIGM CORP ($201,082).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Colin McCracken
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LAB | FLUIDIGM CORP | Chief Commercial Officer | $201,082 | 22 Feb 2022 |
Insider Transactions Reported by Colin McCracken:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.